Nu Skin Enterprises, Inc. (NUS) Given Consensus Recommendation of “Hold” by Analysts

Nu Skin Enterprises, Inc. (NYSE:NUS) has earned a consensus recommendation of “Hold” from the eleven brokerages that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $65.38.

Several research analysts have recently commented on the company. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Citigroup reiterated a “buy” rating and issued a $81.00 target price (up previously from $70.00) on shares of Nu Skin Enterprises in a research report on Tuesday, January 23rd. Finally, Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 target price for the company in a research report on Saturday, December 30th.

In other news, Chairman Steven Lund sold 42,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $68.11, for a total value of $2,860,620.00. Following the completion of the transaction, the chairman now owns 4,769 shares in the company, valued at approximately $324,816.59. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last quarter, insiders sold 195,978 shares of company stock valued at $13,512,733. Insiders own 5.20% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in NUS. Cerebellum GP LLC acquired a new position in Nu Skin Enterprises during the 4th quarter valued at approximately $124,000. Migdal Insurance & Financial Holdings Ltd. acquired a new position in Nu Skin Enterprises during the 3rd quarter valued at approximately $148,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Nu Skin Enterprises by 38.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock valued at $210,000 after purchasing an additional 858 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in Nu Skin Enterprises during the 3rd quarter valued at approximately $219,000. Finally, Virtu Financial LLC acquired a new position in Nu Skin Enterprises during the 4th quarter valued at approximately $220,000. Institutional investors and hedge funds own 78.00% of the company’s stock.

Shares of Nu Skin Enterprises (NYSE:NUS) traded up $0.94 on Friday, hitting $67.60. The stock had a trading volume of 444,686 shares, compared to its average volume of 326,632. The firm has a market cap of $3,509.65, a price-to-earnings ratio of 24.76, a price-to-earnings-growth ratio of 2.07 and a beta of 1.46. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a one year low of $47.10 and a one year high of $74.45.

ILLEGAL ACTIVITY NOTICE: “Nu Skin Enterprises, Inc. (NUS) Given Consensus Recommendation of “Hold” by Analysts” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.com-unik.info/2018/02/10/nu-skin-enterprises-inc-nus-given-consensus-recommendation-of-hold-by-analysts.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit